Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.

Clinical trial NCT03644303 · COMPLETED

Trial details

NCT number: NCT03644303
Sponsor: Royal Marsden NHS Foundation Trust
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Prostate Cancer Metastasis Toxicity Due to Radiotherapy Circulating Tumour DNA

Start date: 2018-08-13
Primary completion: 2025-03-31
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.